Share This

Related Topics News -

     
 Detail   |   Print 
     
三葉草生物-B二價RSV候選疫苗I期臨床試驗獲積極初步數據
2024-04-08T  
《公司業績》三葉草生物-B去年虧損收窄至1.39億人幣 不派末期息
2024-03-27T  
醫藥股普遍造好 藥明系揚6%-8% 科倫博泰漲逾7%創上市新高
2024-03-25T  
《異動股》君聖泰及聖諾挫14% 科倫博泰生物漲12%
2024-03-13T  
恆指跌幅曾擴至620點 藥股捱沽 榮昌生物急挫21%
2024-01-17T  
三葉草生物(02197.HK)回應新冠疫苗生產:適時調整業務資源投入
2024-01-11T  
恆指跌近400點 醫藥股普遍捱沽 威高股份及中國中藥齊挫14%
2024-01-08T  
三葉草生物-B(02197.HK)治療血小板減少症藥物臨床試驗獲積極初步數據
2023-12-29T  
三葉草生物-B(02197.HK)與Genhunter版稅費將於下一份年報披露
2023-12-28T  
三葉草生物-B(02197.HK)RSV候選疫苗I期臨床試驗首批受試者完成入組
2023-12-13T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.